Home » News » India » US Officials Seek To Know If Third Dose Helps Some
1-MIN READ

US Officials Seek To Know If Third Dose Helps Some

The court sought the law ministry’s response after going through a statement by the World Health Organisation, which has declared virginity testing as unscientific, medically unnecessary and unreliable.

The court sought the law ministry’s response after going through a statement by the World Health Organisation, which has declared virginity testing as unscientific, medically unnecessary and unreliable.

Washington (AP) Federal health officials have signalled they're hunting ways to quickly learn if a third COVID-19 vaccine dose might better protect organ transplant recipients and other patients with weak immune systems. While the vaccines are strongly effective in most people, many Americans with immune-suppressing health problems remain in limbo after immunisation, uncertain how protected they really are. France and Israel already have begun offering an extra dose to transplant recipients and other immunocompromised people. In the US, those patients increasingly are pushing for -- even lying to get -- another shot, too..

Washington (AP) Federal health officials have signalled they’re hunting ways to quickly learn if a third COVID-19 vaccine dose might better protect organ transplant recipients and other patients with weak immune systems. While the vaccines are strongly effective in most people, many Americans with immune-suppressing health problems remain in limbo after immunisation, uncertain how protected they really are. France and Israel already have begun offering an extra dose to transplant recipients and other immunocompromised people. In the US, those patients increasingly are pushing for — even lying to get — another shot, too.

Thursday, advisers to the Centers for Disease Control and Prevention reviewed some small studies that hint, but don’t prove, a third dose might help at least some immunocompromised patients. The panel can’t formally recommend an extra dose without the Food and Drug Administration’s permission, but several advisers asked if the government could allow worried patients to sign up for one as part of a study. “We are actively looking into ways that could be done," replied CDC’s Dr Amanda Cohn. “Stay tuned. We are working through those issues." (AP) .

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Read all the Latest News, Breaking News and Coronavirus News here

first published:July 23, 2021, 03:30 IST